Titre : Visiteurs des patients

Visiteurs des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Dactinomycin

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment évaluer l'impact des visites sur le patient ?

L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel.
Évaluation Bien-être Visiteurs
#2

Quels signes indiquent qu'un patient a besoin de visites ?

Un patient peut montrer des signes de solitude, d'anxiété ou de dépression.
Solitude Anxiété Dépression

Symptômes 2

#1

Quels symptômes peuvent s'aggraver sans visites ?

L'isolement social peut aggraver l'anxiété et la dépression chez le patient.
Isolement social Anxiété Dépression
#2

Les visites peuvent-elles réduire la douleur perçue ?

Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur.
Douleur Soutien émotionnel Visiteurs

Prévention 2

#1

Comment prévenir l'isolement des patients ?

Encourager les visites régulières et utiliser des technologies de communication.
Isolement Visites Technologie
#2

Quelles mesures prendre pour des visites sûres ?

Respecter les protocoles d'hygiène et les restrictions de visite en place.
Hygiène Protocoles Visiteurs

Traitements 2

#1

Les visites font-elles partie du traitement ?

Oui, les visites peuvent être considérées comme un complément au traitement médical.
Traitement Soutien social Visiteurs
#2

Comment les hôpitaux gèrent-ils les visites ?

Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients.
Gestion des visites Sécurité Hôpital

Complications 2

#1

Quelles complications peuvent survenir sans visites ?

L'absence de visites peut entraîner une détérioration de la santé mentale et physique.
Complications Santé mentale Santé physique
#2

Les visites peuvent-elles causer du stress au patient ?

Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress.
Stress Visiteurs Planification

Facteurs de risque 2

#1

Quels facteurs augmentent le besoin de visites ?

L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin.
Âge avancé Maladies chroniques Isolement social
#2

Les patients en soins intensifs ont-ils plus besoin de visites ?

Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs.
Soins intensifs Soutien Visiteurs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Visiteurs des patients : Questions médicales les plus fréquentes", "headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Visiteurs des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Visiteurs des patients", "alternateName": "Visitors to Patients", "code": { "@type": "MedicalCode", "code": "D014789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Samantha J Chiew", "url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Paul H Hemsworth", "url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Sally L Sherwen", "url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen", "affiliation": { "@type": "Organization", "name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia." } }, { "@type": "Person", "name": "Grahame J Coleman", "url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Vicky Melfi", "url": "https://questionsmedicales.fr/author/Vicky%20Melfi", "affiliation": { "@type": "Organization", "name": "Hartpury University and Hartpury College, Gloucester, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Mechanistic modelling of targeted pulmonary delivery of dactinomycin iron oxide-loaded nanoparticles for lung cancer therapy.", "datePublished": "2022-12-16", "url": "https://questionsmedicales.fr/article/36416448", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/10837450.2022.2152047" } }, { "@type": "ScholarlyArticle", "name": "Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.", "datePublished": "2023-03-17", "url": "https://questionsmedicales.fr/article/36934478", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ygyno.2023.03.007" } }, { "@type": "ScholarlyArticle", "name": "Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36250317", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijc.34326" } }, { "@type": "ScholarlyArticle", "name": "Current status and future perspectives in targeted therapy of NPM1-mutated AML.", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36008542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41375-022-01666-2" } }, { "@type": "ScholarlyArticle", "name": "CircZNF644 aggravates lipopolysaccharide-induced HK-2 cell impairment via the miR-140-5p/MLKL axis.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35976517", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10863-022-09946-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Visiteurs des patients", "item": "https://questionsmedicales.fr/mesh/D014789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Visiteurs des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Visiteurs des patients", "description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Dactinomycin#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Visiteurs des patients", "description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Dactinomycin#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Visiteurs des patients", "description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Dactinomycin#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Visiteurs des patients", "description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Dactinomycin#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Visiteurs des patients", "description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Dactinomycin#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Visiteurs des patients", "description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Dactinomycin#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact des visites sur le patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel." } }, { "@type": "Question", "name": "Quels signes indiquent qu'un patient a besoin de visites ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression." } }, { "@type": "Question", "name": "Quels symptômes peuvent s'aggraver sans visites ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient." } }, { "@type": "Question", "name": "Les visites peuvent-elles réduire la douleur perçue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur." } }, { "@type": "Question", "name": "Comment prévenir l'isolement des patients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Encourager les visites régulières et utiliser des technologies de communication." } }, { "@type": "Question", "name": "Quelles mesures prendre pour des visites sûres ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les protocoles d'hygiène et les restrictions de visite en place." } }, { "@type": "Question", "name": "Les visites font-elles partie du traitement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les visites peuvent être considérées comme un complément au traitement médical." } }, { "@type": "Question", "name": "Comment les hôpitaux gèrent-ils les visites ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans visites ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique." } }, { "@type": "Question", "name": "Les visites peuvent-elles causer du stress au patient ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de visites ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin." } }, { "@type": "Question", "name": "Les patients en soins intensifs ont-ils plus besoin de visites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 26/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Samantha J Chiew

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Paul H Hemsworth

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Sally L Sherwen

3 publications dans cette catégorie

Affiliations :
  • Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia.
Publications dans "Visiteurs des patients" :

Grahame J Coleman

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Vicky Melfi

2 publications dans cette catégorie

Affiliations :
  • Hartpury University and Hartpury College, Gloucester, United Kingdom.
Publications dans "Visiteurs des patients" :

Yongchao Hou

2 publications dans cette catégorie

Affiliations :
  • Emergency Department, ShanXi Provincial People's Hospital, Taiyuan, ShanXi, China.
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Melissa Corbally

2 publications dans cette catégorie

Affiliations :
  • School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Fiona Timmins

2 publications dans cette catégorie

Affiliations :
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Jocelyn A Srigley

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: jocelyn.srigley@cw.bc.ca.

Amy Damashek

2 publications dans cette catégorie

Affiliations :
  • Western Michigan University, Kalamazoo, USA.
Publications dans "Visiteurs des patients" :

Emily A Vargas

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Publications dans "Visiteurs des patients" :

Ramaswami Mahalingam

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Riley A Marshall

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Mark Otieno

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
  • Department of Agricultural Resource Management, University of Embu, Embu, Kenya.
Publications dans "Visiteurs des patients" :

Neelendra Joshi

1 publication dans cette catégorie

Affiliations :
  • Department of Entomology and Plant Pathology, University of Arkansas at Fayetteville, Fayetteville, AR, USA.
Publications dans "Visiteurs des patients" :

Benjamin Rutschmann

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
Publications dans "Visiteurs des patients" :

Audra N Iness

1 publication dans cette catégorie

Affiliations :
  • Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, Va; Department of Pediatrics, Baylor College of Medicine, Houston, Tex. Electronic address: audra.iness@bcm.edu.

Jefferson O Abaricia

1 publication dans cette catégorie

Affiliations :
  • Department of Bioengineering, College of Engineering, Virginia Commonwealth University, Richmond, Va.

Wendemi Sawadogo

1 publication dans cette catégorie

Affiliations :
  • Division of Epidemiology, Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, Va.

Caleb M Iness

1 publication dans cette catégorie

Affiliations :
  • School of Medicine, California Northstate University, Elk Grove, Calif.

Sources (38 au total)

Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.

Gestational Trophoblastic Neoplasia (GTN) is a rare group of malignant placental-related tumours requiring systemic anti-cancer treatment. Leptomeningeal disease (LMD) related to GTN is not well repor... We discuss five patients with GTN who presented with features of LMD and were diagnosed with gadolinium-enhanced MRI brain, all of whom received low dose induction etoposide-cisplatin (EP) followed by... Four out of the five patients additionally received intrathecal methotrexate. Four patients had complete hCG response to first line multi-agent chemotherapy, one patient required second line paclitaxe... With a follow-up range of 2-6 years, all five patients remain cured demonstrating excellent survival outcomes with the avoidance of whole-brain radiotherapy in all cases....

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

In Euro-EWING99-R1 randomized trial, cyclophosphamide was shown to be noninferior to ifosfamide in the consolidation of standard-risk Ewing sarcoma (SR-EWS) after a common induction with VIDE (vincris...

Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia.

There are few multinational studies on gestational trophoblastic neoplasia (GTN) treatment outcomes in South America. The purpose of this study was to assess the clinical presentation, treatment outco... Multicentric, historical cohort study including women with International Federation of Gynecology and Obstetrics (FIGO)-staged low-risk postmolar GTN attending centers in Argentina, Brazil, and Colomb... A total of 163 women with low-risk GTN were included in the analysis. The overall rate of complete response to first-line chemotherapy was 80% (130/163). The rates of complete response to methotrexate... 1) At presentation, most women showed clinical characteristics favorable to a good outcome, 2) the overall rate of sustained complete remission after first-line single-agent treatment was comparable t...

Metastatic Rhabdomyosarcoma: Results of the European

Outcome for patients with metastatic rhabdomyosarcoma (RMS) is poor. This study presents the results of the MTS 2008 study with a pooled analysis including patients from the concurrent BERNIE study.... In MTS 2008, patients with metastatic RMS received four cycles of ifosfamide, vincristine, and actinomycin D (IVA) plus doxorubicin, five cycles of IVA, and 12 cycles of maintenance chemotherapy (low-... MTS 2008 included 270 patients (median age, 9.6 years; range, 0.07-20.8 years). With a median follow-up of 50.3 months, 3-year event-free survival (EFS) and overall survival (OS) were 34.9% (95% CI, 2... Outcome remains poor for patients with metastatic RMS and multiple ORFs. Because of the design of the studies, it was not possible to determine whether the intensive induction regimen and/or the addit...

Pulmonary metastatic gestational choriocarcinoma following an uncomplicated term pregnancy: a case report.

Choriocarcinoma is a highly malignant pregnancy-related trophoblastic neoplasm, characterized by early metastasis to the lungs. Therefore, patients may manifest nongynecological symptoms owing to dist... We report a case of a 20-year-old Iranian woman, gravida 2 para 1 live 1 abortion 1, who was referred to our gynecology department with sudden onset dyspnea and pain in the left hemithorax the day aft... The prognosis of choriocarcinoma is very good if the treatment is started on time. We suggest that clinicians should consider gestational trophoblastic neoplasia in their differential diagnosis of the...

Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases.

To evaluate the efficacy of immunotherapy for GTN treatment after methotrexate-resistance or in cases of multiresistant disease, through a systematic review, as well as to present the first 4 Brazilia... Three independent researchers searched five electronic databases (EMBASE, LILACS, Medline, CENTRAL and Web of Science), for relevant articles up to February/2023 (PROSPERO CRD42023401453). The quality... Of the 4 cases presented, the first was a low-risk GTN with methotrexate resistance unsuccessfully treated with avelumab, which achieved remission with sequential multiagent chemotherapy. The remainin... Immunotherapy showed effectiveness for GTN treatment and may be especially useful in cases of high-risk disease, where pembrolizumab achieves a high therapeutic response, regardless of the histologica...

Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.

High-risk gestational trophoblastic neoplasia (GTN) is rare and treated with diverse approaches. Limited published institutional data has yet to be systematically reviewed.... To compile global high-risk GTN (prognostic score ≥7) cohorts to summarise treatments and outcomes by disease characteristics and primary chemotherapy.... MEDLINE, Embase, Scopus, ClinicalTrials.gov and Cochrane were searched through March 2021.... Full-text manuscripts reporting mortality among ≥10 high-risk GTN patients.... Binomial proportions were summed, and random-effects meta-analyses performed.... From 1137 records, we included 35 studies, representing 20 countries. Among 2276 unique high-risk GTN patients, 99.7% received chemotherapy, 35.8% surgery and 4.9% radiation. Mortality was 10.9% (243/... High-risk GTN is responsive to several chemotherapy regimens, with EMA/CO or EMA/EP associated with improved outcomes. Mortality is increased in patients with ultra-high-risk, relapsed and post-term p...